Fresenius SE Revenue 2016-2023 | FSNUY

Fresenius SE annual/quarterly revenue history and growth rate from 2016 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Fresenius SE revenue for the quarter ending September 30, 2023 was $6.006B, a 42.99% decline year-over-year.
  • Fresenius SE revenue for the twelve months ending September 30, 2023 was $39.203B, a 9.93% decline year-over-year.
  • Fresenius SE annual revenue for 2022 was $43.029B, a 3.07% decline from 2021.
  • Fresenius SE annual revenue for 2021 was $44.39B, a 7.12% increase from 2020.
  • Fresenius SE annual revenue for 2020 was $41.439B, a 4.49% increase from 2019.
Fresenius SE Annual Revenue
(Millions of US $)
2022 $43,029
2021 $44,390
2020 $41,439
2019 $39,658
2018 $39,599
2017 $38,301
2016 $32,183
2015 $30,676
Fresenius SE Quarterly Revenue
(Millions of US $)
2023-09-30 $6,006
2023-06-30 $11,295
2023-03-31 $10,976
2022-12-31 $10,926
2022-09-30 $10,534
2022-06-30 $10,661
2022-03-31 $10,908
2021-12-31 $11,423
2021-09-30 $10,995
2021-06-30 $11,141
2021-03-31 $10,831
2020-12-31 $11,115
2020-09-30 $10,425
2020-06-30 $9,822
2020-03-31 $10,078
2019-12-31 $10,330
2019-09-30 $9,832
2019-06-30 $9,847
2019-03-31 $9,649
2018-12-31 $10,095
2018-09-30 $9,525
2018-06-30 $9,996
2018-03-31 $9,982
2017-12-31 $10,254
2017-09-30 $9,751
2017-06-30 $9,384
2017-03-31 $8,911
2016-12-31 $8,423
2016-09-30 $8,121
2016-06-30 $8,011
2016-03-31 $7,628
2015-12-31 $7,951
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.002B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00